nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP2C19—Esomeprazole—Barrett's esophagus	0.202	0.283	CbGbCtD
Lapatinib—CYP2C8—Omeprazole—Barrett's esophagus	0.142	0.199	CbGbCtD
Lapatinib—CYP2C19—Omeprazole—Barrett's esophagus	0.119	0.167	CbGbCtD
Lapatinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0977	0.137	CbGbCtD
Lapatinib—ABCB1—Omeprazole—Barrett's esophagus	0.0961	0.134	CbGbCtD
Lapatinib—CYP3A4—Omeprazole—Barrett's esophagus	0.0576	0.0806	CbGbCtD
Lapatinib—ERBB2—exocrine gland—Barrett's esophagus	0.015	0.298	CbGeAlD
Lapatinib—ERBB2—epithelium—Barrett's esophagus	0.00654	0.13	CbGeAlD
Lapatinib—ERBB4—epithelium—Barrett's esophagus	0.00654	0.13	CbGeAlD
Lapatinib—ERBB2—smooth muscle tissue—Barrett's esophagus	0.0063	0.125	CbGeAlD
Lapatinib—PI4KB—smooth muscle tissue—Barrett's esophagus	0.0059	0.117	CbGeAlD
Lapatinib—TAP1—Mecp2 and Associated Rett Syndrome—SST—Barrett's esophagus	0.00518	0.0619	CbGpPWpGaD
Lapatinib—ERBB2—digestive system—Barrett's esophagus	0.00498	0.0986	CbGeAlD
Lapatinib—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.00401	0.0265	CcSEcCtD
Lapatinib—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.00401	0.0265	CcSEcCtD
Lapatinib—TAP1—Direct p53 effectors—MCL1—Barrett's esophagus	0.00374	0.0446	CbGpPWpGaD
Lapatinib—Hot flush—Omeprazole—Barrett's esophagus	0.00283	0.0187	CcSEcCtD
Lapatinib—Hot flush—Esomeprazole—Barrett's esophagus	0.00283	0.0187	CcSEcCtD
Lapatinib—Menopausal symptoms—Esomeprazole—Barrett's esophagus	0.00281	0.0185	CcSEcCtD
Lapatinib—Menopausal symptoms—Omeprazole—Barrett's esophagus	0.00281	0.0185	CcSEcCtD
Lapatinib—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00265	0.0175	CcSEcCtD
Lapatinib—Pain in extremity—Omeprazole—Barrett's esophagus	0.00265	0.0175	CcSEcCtD
Lapatinib—Dry skin—Esomeprazole—Barrett's esophagus	0.00243	0.016	CcSEcCtD
Lapatinib—Dry skin—Omeprazole—Barrett's esophagus	0.00243	0.016	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00233	0.0154	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00233	0.0154	CcSEcCtD
Lapatinib—PIK3C2B—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00216	0.0258	CbGpPWpGaD
Lapatinib—Neutropenia—Esomeprazole—Barrett's esophagus	0.00214	0.0141	CcSEcCtD
Lapatinib—Neutropenia—Omeprazole—Barrett's esophagus	0.00214	0.0141	CcSEcCtD
Lapatinib—Infestation—Esomeprazole—Barrett's esophagus	0.00204	0.0135	CcSEcCtD
Lapatinib—Infestation—Omeprazole—Barrett's esophagus	0.00204	0.0135	CcSEcCtD
Lapatinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00204	0.0135	CcSEcCtD
Lapatinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.00204	0.0135	CcSEcCtD
Lapatinib—ERBB2—Extracellular vesicle-mediated signaling in recipient cells—HGF—Barrett's esophagus	0.00202	0.0241	CbGpPWpGaD
Lapatinib—Stomatitis—Omeprazole—Barrett's esophagus	0.00199	0.0131	CcSEcCtD
Lapatinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.00199	0.0131	CcSEcCtD
Lapatinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00193	0.0127	CcSEcCtD
Lapatinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00193	0.0127	CcSEcCtD
Lapatinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.00192	0.0127	CcSEcCtD
Lapatinib—Epistaxis—Omeprazole—Barrett's esophagus	0.00192	0.0127	CcSEcCtD
Lapatinib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.0018	0.0119	CcSEcCtD
Lapatinib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.0018	0.0119	CcSEcCtD
Lapatinib—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00169	0.0202	CbGpPWpGaD
Lapatinib—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00165	0.0109	CcSEcCtD
Lapatinib—Immune system disorder—Omeprazole—Barrett's esophagus	0.00165	0.0109	CcSEcCtD
Lapatinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00165	0.0109	CcSEcCtD
Lapatinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00165	0.0109	CcSEcCtD
Lapatinib—Alopecia—Omeprazole—Barrett's esophagus	0.00162	0.0107	CcSEcCtD
Lapatinib—Alopecia—Esomeprazole—Barrett's esophagus	0.00162	0.0107	CcSEcCtD
Lapatinib—Mental disorder—Omeprazole—Barrett's esophagus	0.0016	0.0106	CcSEcCtD
Lapatinib—Mental disorder—Esomeprazole—Barrett's esophagus	0.0016	0.0106	CcSEcCtD
Lapatinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.00159	0.0105	CcSEcCtD
Lapatinib—Malnutrition—Omeprazole—Barrett's esophagus	0.00159	0.0105	CcSEcCtD
Lapatinib—TAP1—Direct p53 effectors—HGF—Barrett's esophagus	0.00157	0.0187	CbGpPWpGaD
Lapatinib—CYP2C19—digestive system—Barrett's esophagus	0.00155	0.0307	CbGeAlD
Lapatinib—Back pain—Omeprazole—Barrett's esophagus	0.00154	0.0102	CcSEcCtD
Lapatinib—Back pain—Esomeprazole—Barrett's esophagus	0.00154	0.0102	CcSEcCtD
Lapatinib—ERBB2—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.0015	0.0179	CbGpPWpGaD
Lapatinib—Anaemia—Omeprazole—Barrett's esophagus	0.00147	0.00973	CcSEcCtD
Lapatinib—Anaemia—Esomeprazole—Barrett's esophagus	0.00147	0.00973	CcSEcCtD
Lapatinib—Leukopenia—Omeprazole—Barrett's esophagus	0.00143	0.00942	CcSEcCtD
Lapatinib—Leukopenia—Esomeprazole—Barrett's esophagus	0.00143	0.00942	CcSEcCtD
Lapatinib—Palpitations—Omeprazole—Barrett's esophagus	0.00141	0.0093	CcSEcCtD
Lapatinib—Palpitations—Esomeprazole—Barrett's esophagus	0.00141	0.0093	CcSEcCtD
Lapatinib—Cough—Omeprazole—Barrett's esophagus	0.00139	0.00919	CcSEcCtD
Lapatinib—Cough—Esomeprazole—Barrett's esophagus	0.00139	0.00919	CcSEcCtD
Lapatinib—Myalgia—Omeprazole—Barrett's esophagus	0.00136	0.00896	CcSEcCtD
Lapatinib—Arthralgia—Esomeprazole—Barrett's esophagus	0.00136	0.00896	CcSEcCtD
Lapatinib—Arthralgia—Omeprazole—Barrett's esophagus	0.00136	0.00896	CcSEcCtD
Lapatinib—Myalgia—Esomeprazole—Barrett's esophagus	0.00136	0.00896	CcSEcCtD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00136	0.0162	CbGpPWpGaD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00135	0.0089	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00135	0.0089	CcSEcCtD
Lapatinib—PIK3C2B—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.00134	0.016	CbGpPWpGaD
Lapatinib—PIK3C2B—DNA Damage Response (only ATM dependent)—APC—Barrett's esophagus	0.00131	0.0157	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.00131	0.0156	CbGpPWpGaD
Lapatinib—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.0013	0.00859	CcSEcCtD
Lapatinib—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.0013	0.00859	CcSEcCtD
Lapatinib—Infection—Esomeprazole—Barrett's esophagus	0.00129	0.00854	CcSEcCtD
Lapatinib—Infection—Omeprazole—Barrett's esophagus	0.00129	0.00854	CcSEcCtD
Lapatinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00128	0.00843	CcSEcCtD
Lapatinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00128	0.00843	CcSEcCtD
Lapatinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.00126	0.00835	CcSEcCtD
Lapatinib—Skin disorder—Omeprazole—Barrett's esophagus	0.00126	0.00835	CcSEcCtD
Lapatinib—Anorexia—Esomeprazole—Barrett's esophagus	0.00124	0.00819	CcSEcCtD
Lapatinib—Anorexia—Omeprazole—Barrett's esophagus	0.00124	0.00819	CcSEcCtD
Lapatinib—EGFR—Hair Follicle Development: Induction (Part 1 of 3)—BMP4—Barrett's esophagus	0.00123	0.0147	CbGpPWpGaD
Lapatinib—CYP3A5—digestive system—Barrett's esophagus	0.00122	0.0242	CbGeAlD
Lapatinib—ERBB2—Bladder Cancer—CDKN2A—Barrett's esophagus	0.00119	0.0142	CbGpPWpGaD
Lapatinib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00119	0.00783	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00119	0.00783	CcSEcCtD
Lapatinib—Insomnia—Omeprazole—Barrett's esophagus	0.00118	0.00777	CcSEcCtD
Lapatinib—Insomnia—Esomeprazole—Barrett's esophagus	0.00118	0.00777	CcSEcCtD
Lapatinib—TAP1—Direct p53 effectors—APC—Barrett's esophagus	0.00117	0.0139	CbGpPWpGaD
Lapatinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00116	0.00766	CcSEcCtD
Lapatinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.00116	0.00766	CcSEcCtD
Lapatinib—Dyspepsia—Omeprazole—Barrett's esophagus	0.00115	0.00756	CcSEcCtD
Lapatinib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00115	0.00756	CcSEcCtD
Lapatinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.00113	0.00747	CcSEcCtD
Lapatinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00113	0.00747	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00112	0.00742	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00112	0.00742	CcSEcCtD
Lapatinib—Fatigue—Esomeprazole—Barrett's esophagus	0.00112	0.00741	CcSEcCtD
Lapatinib—Fatigue—Omeprazole—Barrett's esophagus	0.00112	0.00741	CcSEcCtD
Lapatinib—Constipation—Esomeprazole—Barrett's esophagus	0.00111	0.00735	CcSEcCtD
Lapatinib—Constipation—Omeprazole—Barrett's esophagus	0.00111	0.00735	CcSEcCtD
Lapatinib—CYP2C8—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00108	0.0129	CbGpPWpGaD
Lapatinib—ERBB2—Bladder Cancer—CXCL8—Barrett's esophagus	0.00108	0.0129	CbGpPWpGaD
Lapatinib—PIK3C2B—DNA Damage Response (only ATM dependent)—CDKN2A—Barrett's esophagus	0.00107	0.0127	CbGpPWpGaD
Lapatinib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00106	0.00703	CcSEcCtD
Lapatinib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00106	0.00703	CcSEcCtD
Lapatinib—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00104	0.0125	CbGpPWpGaD
Lapatinib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00103	0.00679	CcSEcCtD
Lapatinib—Abdominal pain—Omeprazole—Barrett's esophagus	0.00103	0.00679	CcSEcCtD
Lapatinib—PIK3C2B—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.00102	0.0122	CbGpPWpGaD
Lapatinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—HGF—Barrett's esophagus	0.000977	0.0117	CbGpPWpGaD
Lapatinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000972	0.0116	CbGpPWpGaD
Lapatinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000972	0.0116	CbGpPWpGaD
Lapatinib—CYP2C19—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.000965	0.0115	CbGpPWpGaD
Lapatinib—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000959	0.00633	CcSEcCtD
Lapatinib—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000959	0.00633	CcSEcCtD
Lapatinib—Asthenia—Esomeprazole—Barrett's esophagus	0.000934	0.00617	CcSEcCtD
Lapatinib—Asthenia—Omeprazole—Barrett's esophagus	0.000934	0.00617	CcSEcCtD
Lapatinib—Pruritus—Esomeprazole—Barrett's esophagus	0.000921	0.00608	CcSEcCtD
Lapatinib—Pruritus—Omeprazole—Barrett's esophagus	0.000921	0.00608	CcSEcCtD
Lapatinib—CYP3A4—digestive system—Barrett's esophagus	0.000916	0.0181	CbGeAlD
Lapatinib—CYP3A5—Irinotecan Pathway—APC—Barrett's esophagus	0.000893	0.0107	CbGpPWpGaD
Lapatinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.00089	0.00588	CcSEcCtD
Lapatinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00089	0.00588	CcSEcCtD
Lapatinib—EGFR—Arf6 signaling events—HGF—Barrett's esophagus	0.000864	0.0103	CbGpPWpGaD
Lapatinib—ABCB1—epithelium—Barrett's esophagus	0.000852	0.0169	CbGeAlD
Lapatinib—Vomiting—Esomeprazole—Barrett's esophagus	0.000827	0.00546	CcSEcCtD
Lapatinib—Vomiting—Omeprazole—Barrett's esophagus	0.000827	0.00546	CcSEcCtD
Lapatinib—Rash—Omeprazole—Barrett's esophagus	0.00082	0.00542	CcSEcCtD
Lapatinib—Rash—Esomeprazole—Barrett's esophagus	0.00082	0.00542	CcSEcCtD
Lapatinib—Dermatitis—Omeprazole—Barrett's esophagus	0.00082	0.00541	CcSEcCtD
Lapatinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.00082	0.00541	CcSEcCtD
Lapatinib—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000818	0.00977	CbGpPWpGaD
Lapatinib—Headache—Esomeprazole—Barrett's esophagus	0.000815	0.00538	CcSEcCtD
Lapatinib—Headache—Omeprazole—Barrett's esophagus	0.000815	0.00538	CcSEcCtD
Lapatinib—CYP3A5—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000807	0.00964	CbGpPWpGaD
Lapatinib—EGFR—Signaling events mediated by TCPTP—HGF—Barrett's esophagus	0.000776	0.00927	CbGpPWpGaD
Lapatinib—Nausea—Omeprazole—Barrett's esophagus	0.000773	0.0051	CcSEcCtD
Lapatinib—Nausea—Esomeprazole—Barrett's esophagus	0.000773	0.0051	CcSEcCtD
Lapatinib—EGFR—Stabilization and expansion of the E-cadherin adherens junction—HGF—Barrett's esophagus	0.000747	0.00892	CbGpPWpGaD
Lapatinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—Barrett's esophagus	0.000747	0.00892	CbGpPWpGaD
Lapatinib—PIK3C2B—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000745	0.0089	CbGpPWpGaD
Lapatinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—APC—Barrett's esophagus	0.000726	0.00867	CbGpPWpGaD
Lapatinib—EGFR—Syndecan-3-mediated signaling events—CXCL8—Barrett's esophagus	0.000711	0.00849	CbGpPWpGaD
Lapatinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000708	0.00846	CbGpPWpGaD
Lapatinib—CYP2C8—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000699	0.00835	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—MCL1—Barrett's esophagus	0.000679	0.00811	CbGpPWpGaD
Lapatinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000663	0.00792	CbGpPWpGaD
Lapatinib—ERBB2—Bladder Cancer—TP53—Barrett's esophagus	0.000661	0.00789	CbGpPWpGaD
Lapatinib—ABCB1—digestive system—Barrett's esophagus	0.000649	0.0128	CbGeAlD
Lapatinib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000632	0.00755	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000625	0.00747	CbGpPWpGaD
Lapatinib—CYP2C19—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000624	0.00745	CbGpPWpGaD
Lapatinib—ERBB2—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000617	0.00737	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—PTGES—Barrett's esophagus	0.000604	0.00721	CbGpPWpGaD
Lapatinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000599	0.00715	CbGpPWpGaD
Lapatinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000599	0.00715	CbGpPWpGaD
Lapatinib—PIK3C2B—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	0.000594	0.00709	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PTGES—Barrett's esophagus	0.000583	0.00696	CbGpPWpGaD
Lapatinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000574	0.00686	CbGpPWpGaD
Lapatinib—EGFR—Bladder Cancer—CDKN2A—Barrett's esophagus	0.000574	0.00686	CbGpPWpGaD
Lapatinib—ERBB2—Leptin signaling pathway—RELA—Barrett's esophagus	0.000564	0.00673	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—SLC9A1—Barrett's esophagus	0.000563	0.00673	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000545	0.00651	CbGpPWpGaD
Lapatinib—ERBB2—DNA Damage Response (only ATM dependent)—APC—Barrett's esophagus	0.000535	0.00639	CbGpPWpGaD
Lapatinib—TAP1—Direct p53 effectors—TP53—Barrett's esophagus	0.000526	0.00629	CbGpPWpGaD
Lapatinib—EGFR—Bladder Cancer—CXCL8—Barrett's esophagus	0.000521	0.00622	CbGpPWpGaD
Lapatinib—CYP2C19—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000513	0.00612	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—HGF—Barrett's esophagus	0.000462	0.00552	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—CYP26A1—Barrett's esophagus	0.000457	0.00546	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—CYP26A1—Barrett's esophagus	0.000442	0.00528	CbGpPWpGaD
Lapatinib—ERBB2—DNA Damage Response (only ATM dependent)—CDKN2A—Barrett's esophagus	0.000434	0.00519	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000426	0.00508	CbGpPWpGaD
Lapatinib—ERBB2—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000424	0.00506	CbGpPWpGaD
Lapatinib—ERBB4—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000418	0.00499	CbGpPWpGaD
Lapatinib—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000415	0.00496	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000414	0.00495	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000403	0.00481	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000391	0.00468	CbGpPWpGaD
Lapatinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00038	0.00454	CbGpPWpGaD
Lapatinib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000375	0.00448	CbGpPWpGaD
Lapatinib—ERBB2—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000357	0.00426	CbGpPWpGaD
Lapatinib—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000352	0.00421	CbGpPWpGaD
Lapatinib—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000347	0.00415	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000341	0.00408	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000338	0.00404	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—SLC9A1—Barrett's esophagus	0.00033	0.00394	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000326	0.0039	CbGpPWpGaD
Lapatinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00032	0.00382	CbGpPWpGaD
Lapatinib—EGFR—Bladder Cancer—TP53—Barrett's esophagus	0.000319	0.00382	CbGpPWpGaD
Lapatinib—EGFR—Gastric Cancer Network 2—TP53—Barrett's esophagus	0.000319	0.00382	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—SLC9A1—Barrett's esophagus	0.000318	0.0038	CbGpPWpGaD
Lapatinib—EGFR—LPA receptor mediated events—RELA—Barrett's esophagus	0.000309	0.00369	CbGpPWpGaD
Lapatinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000308	0.00368	CbGpPWpGaD
Lapatinib—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	0.000305	0.00364	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000303	0.00362	CbGpPWpGaD
Lapatinib—EGFR—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000302	0.0036	CbGpPWpGaD
Lapatinib—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000301	0.00359	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000298	0.00356	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000297	0.00355	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HGF—Barrett's esophagus	0.000294	0.00352	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000293	0.00349	CbGpPWpGaD
Lapatinib—EGFR—LPA receptor mediated events—CXCL8—Barrett's esophagus	0.000291	0.00348	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—HGF—Barrett's esophagus	0.000285	0.0034	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000284	0.00339	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—RELA—Barrett's esophagus	0.000282	0.00336	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000279	0.00334	CbGpPWpGaD
Lapatinib—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000272	0.00325	CbGpPWpGaD
Lapatinib—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000269	0.00321	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000266	0.00318	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000264	0.00315	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—RELA—Barrett's esophagus	0.000262	0.00313	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000259	0.0031	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—RELA—Barrett's esophagus	0.000258	0.00309	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000257	0.00307	CbGpPWpGaD
Lapatinib—ERBB2—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	0.000242	0.00289	CbGpPWpGaD
Lapatinib—EGFR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	0.000238	0.00284	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—HGF—Barrett's esophagus	0.000223	0.00267	CbGpPWpGaD
Lapatinib—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000212	0.00253	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—APC—Barrett's esophagus	0.000212	0.00253	CbGpPWpGaD
Lapatinib—EGFR—ErbB Signaling Pathway—TP53—Barrett's esophagus	0.000205	0.00245	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000201	0.0024	CbGpPWpGaD
Lapatinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000197	0.00235	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—RELA—Barrett's esophagus	0.000193	0.00231	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—RELA—Barrett's esophagus	0.00019	0.00227	CbGpPWpGaD
Lapatinib—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000189	0.00226	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.000184	0.0022	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000179	0.00213	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000172	0.00206	CbGpPWpGaD
Lapatinib—TAP1—Immune System—RELA—Barrett's esophagus	0.000171	0.00204	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000165	0.00197	CbGpPWpGaD
Lapatinib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000164	0.00196	CbGpPWpGaD
Lapatinib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000161	0.00193	CbGpPWpGaD
Lapatinib—ERBB2—Disease—SLC9A1—Barrett's esophagus	0.00016	0.00191	CbGpPWpGaD
Lapatinib—ERBB4—Disease—SLC9A1—Barrett's esophagus	0.000158	0.00189	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000155	0.00185	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000154	0.00184	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—PPARG—Barrett's esophagus	0.000154	0.00184	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—PPARG—Barrett's esophagus	0.000151	0.0018	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000147	0.00175	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—GAST—Barrett's esophagus	0.000146	0.00175	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PPARG—Barrett's esophagus	0.000145	0.00174	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—GAST—Barrett's esophagus	0.000144	0.00172	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000144	0.00172	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000138	0.00165	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000137	0.00164	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—RELA—Barrett's esophagus	0.000127	0.00152	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000125	0.0015	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—RELA—Barrett's esophagus	0.000125	0.00149	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	0.000124	0.00148	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GAST—Barrett's esophagus	0.00012	0.00143	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—PTGS2—Barrett's esophagus	0.000118	0.00141	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—PTGS2—Barrett's esophagus	0.000114	0.00137	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000114	0.00136	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HGF—Barrett's esophagus	0.000111	0.00132	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—RELA—Barrett's esophagus	0.00011	0.00132	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—Barrett's esophagus	0.00011	0.00131	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HGF—Barrett's esophagus	0.000109	0.0013	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—RELA—Barrett's esophagus	0.000109	0.0013	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—RELA—Barrett's esophagus	0.000106	0.00126	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—RELA—Barrett's esophagus	0.000104	0.00124	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SST—Barrett's esophagus	0.0001	0.0012	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SST—Barrett's esophagus	9.88e-05	0.00118	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—Barrett's esophagus	9.56e-05	0.00114	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—RELA—Barrett's esophagus	9.34e-05	0.00112	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	9e-05	0.00108	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	8.33e-05	0.000995	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—Barrett's esophagus	8.27e-05	0.000987	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—SST—Barrett's esophagus	8.21e-05	0.000981	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGES—Barrett's esophagus	7.95e-05	0.000949	CbGpPWpGaD
Lapatinib—EGFR—Disease—SLC9A1—Barrett's esophagus	7.75e-05	0.000926	CbGpPWpGaD
Lapatinib—ERBB2—Disease—APC—Barrett's esophagus	7.58e-05	0.000906	CbGpPWpGaD
Lapatinib—ERBB4—Disease—APC—Barrett's esophagus	7.47e-05	0.000892	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	7.46e-05	0.000891	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—PPARG—Barrett's esophagus	7.45e-05	0.00089	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GAST—Barrett's esophagus	7.08e-05	0.000845	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	6.99e-05	0.000835	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	6.88e-05	0.000822	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—RELA—Barrett's esophagus	6.42e-05	0.000766	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	6.33e-05	0.000755	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—RELA—Barrett's esophagus	6.32e-05	0.000755	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGES—Barrett's esophagus	6.14e-05	0.000734	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—RELA—Barrett's esophagus	6.03e-05	0.00072	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	6.02e-05	0.000719	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	6e-05	0.000716	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—Barrett's esophagus	5.76e-05	0.000688	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—Barrett's esophagus	5.67e-05	0.000677	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HGF—Barrett's esophagus	5.35e-05	0.000639	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—RELA—Barrett's esophagus	5.33e-05	0.000636	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—APC—Barrett's esophagus	5.31e-05	0.000634	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—APC—Barrett's esophagus	5.23e-05	0.000625	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	5.22e-05	0.000623	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—RELA—Barrett's esophagus	5.11e-05	0.000611	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SST—Barrett's esophagus	4.85e-05	0.000579	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	4.66e-05	0.000556	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	4.54e-05	0.000543	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	4.34e-05	0.000518	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RELA—Barrett's esophagus	4.15e-05	0.000495	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RELA—Barrett's esophagus	4.09e-05	0.000488	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL8—Barrett's esophagus	3.91e-05	0.000467	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.85e-05	0.00046	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL8—Barrett's esophagus	3.85e-05	0.00046	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	3.76e-05	0.00045	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	3.76e-05	0.000449	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	3.69e-05	0.000441	CbGpPWpGaD
Lapatinib—EGFR—Disease—APC—Barrett's esophagus	3.67e-05	0.000438	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.44e-05	0.000411	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	3.36e-05	0.000401	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	3.28e-05	0.000391	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL8—Barrett's esophagus	3.2e-05	0.000382	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RELA—Barrett's esophagus	3.1e-05	0.00037	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.03e-05	0.000362	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.8e-05	0.000334	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—Barrett's esophagus	2.78e-05	0.000332	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.71e-05	0.000323	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APC—Barrett's esophagus	2.57e-05	0.000307	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—Barrett's esophagus	2.4e-05	0.000287	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—Barrett's esophagus	2.36e-05	0.000282	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	2.02e-05	0.000241	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RELA—Barrett's esophagus	2.01e-05	0.00024	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.98e-05	0.000237	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL8—Barrett's esophagus	1.89e-05	0.000226	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	1.72e-05	0.000205	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	1.56e-05	0.000186	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARG—Barrett's esophagus	1.53e-05	0.000183	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.5e-05	0.000179	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	1.35e-05	0.000161	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	1.21e-05	0.000144	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	1.18e-05	0.00014	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—Barrett's esophagus	1.16e-05	0.000139	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	9.21e-06	0.00011	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	7.25e-06	8.66e-05	CbGpPWpGaD
